Rate this Article: Structure-Based Drug Repurposing Through Molecular Docking and ADMET Profiling of FDA-Approved Drugs Targeting SARS-CoV-2 Main Protease (Mpro)

Rating (1-10):

5

Comments (SR26201102349): Full Name: Email Address:

Back to Article